Alcon AG vs Avient Corporation — how do they compare? Alcon AG trades at $72.61 (market cap $36.44B), while Avient Corporation trades at $45.51 (market cap $4.17B). The key difference: Alcon AG is far larger — about 8.7× Avient Corporation's market cap, and Avient Corporation pays the higher dividend (2.42%). Which is the better fit depends on your goals.
| ALC | AVNT | |
|---|---|---|
Market Cap | $36.44B | $4.17B |
Sector | Health | Technology |
52-Week High | $90.12 | $45.69 |
52-Week Low | $62.02 | $27.48 |
Enterprise Value | $40.28B | $5.62B |
Dividend Yield | 0.48% | 2.42% |
Trailing returns across standard periods
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Avient Corporation is a global leader in specialized and sustainable material solutions. Formed from the legacy of PolyOne and Clariant’s masterbatch business, it provides highly engineered polymer formulations, color systems, and advanced composites that enhance the performance and sustainability of products in industries like healthcare, defense, and consumer packaging.
Read more on AVNT →